MIAMI BEACH, Fla.
July 18, 2011
/PRNewswire/ -- Biotech pioneer Divine Skin Inc. (DSKX) announced a partnership with
's largest pharmaceutical company, Ranbaxy Laboratories, to sell the DS Laboratories line of topical hair-growth treatments through its massive distribution pipeline.
With its strong presence in the top pharmaceutical markets, Ranbaxy offers Divine Skin an expanded global distribution network. With its innovative line of hair-growth products, Divine Skin offers Ranbaxy several topical formulations proven to work both at the vertex of the scalp and at the hairline, unlike other brands.
"This agreement is a game changer for Divine Skin investors," declared CEO
. "Ranbaxy is certainly has the resources to develop its own hair-growth brand, yet it has chosen to partner with Divine Skin. It's a powerful endorsement of our cutting-edge technologies. Now our challenge is to accelerate production to keep up with sales."
The DS Laboratories brand expands the treatment options available for men and women suffering hair loss and thinning. Products include the Spectral line of leave-in treatments and the Revita line of shampoo, conditioner, and eyelash treatment.
The comprehensive formulas blend various combinations of minoxidil, finasteride, Aminexil, peptides, procyanidin, stem cells, spin traps, dihydrotestosterone inhibitors, and other powerful ingredients. A proprietary Nanosome delivery system encapsulates active compounds for deeper penetration, longer persistence, and greater efficacy.
Ranbaxy Laboratories is a top-20 pharmaceutical company manufacturing a wide range of high-quality generic medications. Headquartered near
, the company has global revenue of
, customers in 125 countries, presence in 46 countries, and manufacturing facilities in seven countries.
Already a manufacturing and distribution powerhouse, the company focuses on research and development of innovative drugs for its future growth (
About Divine Skin
Divine Skin Inc. leads in the development of biotechnology for topical, nutritional, and pharmaceutical therapies. It markets worldwide through online and specialty retailers, cosmetics wholesalers, salons, and medical offices.